Transgenic pR5 mice bear the human FTD Tau mutation P301L with Parkinsonism linked to chromosome 17, which results in Tau hyperphosphorylation and the formation of abnormal Tau filaments and in the absence of amyloid pathology [34, 35]. The gene discussed is MAPT; the disease is frontotemporal dementia.